Hydrochlorothiazide
- Product NDC
- 50090-5672
- Requested package NDC
- 50090-5672-2
- 11-digit product format
- 500905672
- Labeler code
- 50090
- Product ID
- 50090-5672_709be325-c07e-4041-a44c-65a094a50bf8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrochlorothiazide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA078164
- Marketing category
- ANDA
- Marketing start
- 2007-09-19
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 13 mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 50090-5672 | 50090-5672-2 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078164-001 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 12.5MG | CAPSULE / ORAL | AB | 2007-09-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078164-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078164-001 | HYDROCHLOROTHIAZIDE | 12.5MG | CAPSULE / ORAL | AB | 2007-09-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078164-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 82ad0fdf-5d47-4c2d-883b-f28b2d3fb6b0 | 2025-04-29 | Warnings, Adverse reactions | 078164 ANDA078164 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8242c1de-f482-4a85-b977-610e71fa4904 | 2024-10-07 | Warnings, Adverse reactions | 078164 ANDA078164 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Rising Pharma Holdings, Inc. | 33f9c3ae-108d-469e-af6c-8be3b0f83139 | 2024-09-13 | Warnings, Adverse reactions | 078164 ANDA078164 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | e31bd548-29ae-419a-831a-80ebb26e042f | 2024-06-26 | Warnings, Adverse reactions | 078164 ANDA078164 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-5672-0 | 2023-02-07 | C162847 | 48780-1 | f386c64a-49d2-0266-e053-dadaa90a7c1a | Hydrochlorothiazide Capsules USP Rx only |
| 50090-5672-1 | 2023-02-07 | C162847 | 48780-1 | f386c64a-49d2-0266-e053-dadaa90a7c1a | Hydrochlorothiazide Capsules USP Rx only |
| 50090-5672-2 | 2023-02-07 | C162847 | 48780-1 | f386c64a-49d2-0266-e053-dadaa90a7c1a | Hydrochlorothiazide Capsules USP Rx only |
| 50090-5672-3 | 2023-02-07 | C162847 | 48780-1 | f386c64a-49d2-0266-e053-dadaa90a7c1a | Hydrochlorothiazide Capsules USP Rx only |
| 50090-5672-0 | 2023-01-30 | C162847 | 48780-1 | f386c64a-49d2-0266-e053-dadaa90a7c1a | Hydrochlorothiazide Capsules USP Rx only |
| 50090-5672-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-49d2-0266-e053-dadaa90a7c1a | Hydrochlorothiazide Capsules USP Rx only |
| 50090-5672-2 | 2023-01-30 | C162847 | 48780-1 | f386c64a-49d2-0266-e053-dadaa90a7c1a | Hydrochlorothiazide Capsules USP Rx only |
| 50090-5672-3 | 2023-01-30 | C162847 | 48780-1 | f386c64a-49d2-0266-e053-dadaa90a7c1a | Hydrochlorothiazide Capsules USP Rx only |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5672-0 | EA - Each | 50090-5672 | c87b5785-a154-4eba-9c9b-e1b38c020079 | 1 | 2022-10-06 |
| 50090-5672-1 | EA - Each | 50090-5672 | 6301219b-1680-4daf-83ca-cbb53ba0d458 | 1 | 2022-10-06 |
| 50090-5672-2 | EA - Each | 50090-5672 | d2eb8e0c-6753-4dbf-b5eb-842529893513 | 1 | 2022-10-06 |
| 50090-5672-3 | EA - Each | 50090-5672 | 4bd1e052-248a-4ee4-b765-2ce123c38d42 | 1 | 2022-10-06 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5672 | HYDROCHLOROTHIAZIDE CAPSULE [A-S MEDICATION SOLUTIONS] | 5 | Legacy NDC | 20231210_950da977-044b-434e-bc99-ed64d196fd4c.zip |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-5672-2 | 50090567202 | 60 CAPSULE in 1 BOTTLE (50090-5672-2) | 60 capsule | 2021-09-16 | 0000-00-00 | No | No | Current |